Faye Feller is a seasoned medical professional with extensive experience in clinical research and leadership. Currently serving as the Chief Medical Officer at Geron Corporation since April 2019, Faye previously worked as a Clinical Research Physician at Janssen Inc. from February 2015 to March 2019. Prior roles include an Instructor and Fellow at Memorial Sloan Kettering Cancer Center between July 2010 and January 2015, as well as an Internal Medicine Resident at Icahn School of Medicine at Mount Sinai from July 2007 to June 2010. Faye earned a Doctor of Medicine degree from Icahn School of Medicine at Mount Sinai and a Bachelor of Arts in Biology from New York University.
This person is not in any offices
Geron
4 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.